Moderna’s RSV vaccine gets approval in Canada
CANADA —Moderna’s mRNA vaccine, mRESVIA, has received approval from Health Canada for use in...
Read MoreSelect Page
Nov 12, 2024
CANADA —Moderna’s mRNA vaccine, mRESVIA, has received approval from Health Canada for use in...
Read MoreNov 11, 2024
USA – Moderna, the biotech company known for pioneering work in messenger RNA (mRNA) vaccines, has...
Read MoreAug 27, 2024
JAPAN— Moderna, Inc., a global pioneer in mRNA medication development, has been granted permission...
Read MoreJul 10, 2024
JAPAN— Moderna, a leading mRNA vaccine developer, and Mitsubishi Tanabe Pharma Corporation (MTPC),...
Read MoreJun 6, 2024
USA— Moderna and its partner Merck have made a groundbreaking discovery in the fight against...
Read MoreMay 13, 2024
USA —Moderna, an established pharmaceutical and biotechnology firm based in Cambridge,...
Read MoreMay 7, 2024
USA – Moderna Inc., a pioneering force in mRNA medicine, grappled with significant financial...
Read MoreApr 12, 2024
KENYA—Moderna, the US biotechnology giant, has announced a temporary halt to its plans to...
Read MoreJan 17, 2024
USA – The Health Emergency Preparedness and Response Authority (HERA) of the European Commission...
Read MoreDec 13, 2023
USA — Moderna, a key player in the biotech industry, has announced significant changes to its...
Read More